高佳
发布时间:2026-03-30

高佳,校聘教授,博士生导师


电子邮箱jiagao1988@ahmu.edu.cn


研究方向:先导化合物发现与靶点鉴定;药物筛选技术与方法学创新;


教育经历:

(1)2010.09-2016.06  中国科学技术大学,结构生物学,博士(硕博连读)

(2)2006.09-2010.07  贵州大学,生物技术,学士


学术荣誉:

2022 入选中国科学技术大学“墨子杰出青年特资津贴” 二等资助

2016.09 获得“中国科学技术大学博士论文创优基金” 资助

2013.10 第四届 全国跨学科蛋白质会议 | 口头报告 三等奖


科研项目:

(1)国家自然科学青年科学基金项目(C类),21703254, 2018.01-2020.12,主持;

(2)安徽省自然科学基金面上项目,2208085MC50, 2022.01-2024.12,主持;

(3)“科大新医学”联合基金,YD9100002036,,2023.01-2024.12,主持;

(4)横向技术服务,EF9100000028, 2022.09-2024.07,主持;

(5)国家自然科学青年国家重点研发计划, 2025.01-2029.12,骨干;


发表论文情况

[1] Wang L, Li Z, Xuan Y, Qin J, Li S, Zhong F, Song Y, Yang K, Lv M, Li F, Jiahai Z, Pan Y, Guang S, Zhao Y, Shi Y, Liu X*, Du Y*, Gao J*, Ruan K*. Comprehensive profiling of the catalytic conformations of human Guanylate kinase. Nat Commun. 2025 Jul 25;16(1):6859. doi: 10.1038/s41467-025-61732-y. PMID: 40715061; PMCID: PMC12297293.

[3] Jiao Li, Fumei Zhong, Mingwei Li, Yaqian Liu, Lei Wang, Mingqing Liu, Fudong Li, J. Zhang, J. Wu, Yunyu Shi, Zhiyong Zhang, Xiaoming Tu, Ke Ruan*, and Jia Gao*,“Two Binding Sites of SARA-CoV-2 Macrodomain 3 Probed by Oxaprozin and Meclomen” J. Med. Chem.  2022 65 (22), 15227-15237.

[2] Gao J#, Liang E#, Ma R, Li F, Liu Y, Liu J, Jiang L, Li C, Dai H, Wu J, Su X, He W, Ruan K*.“Fluorine Pseudocontact Shifts Used for Characterizing the Protein-Ligand Interaction Mode in the limit of NMR Intermediate Exchange”. Angew. Chem. Int. Ed. 2017, 56:12982-12986.

[4]Gao J#, Zhang L#, Liu X, Li F, Ma R, Zhu Z, Zhang J, Wu J, Shi Y, Pan Y, Ge Y*, Ruan K*. “Repurposing low–molecular-weight drugs against the main protease of severe acute respiratory syndrome coronavirus 2”. J. Phys. Chem. Lett. 2020, 11:7267–7272.

[5] Lv M#, Gao J#, Li M#, Ma R, Li F, Liu Y, Liu M, Zhang J, Yao X, Wu J, Shi Y, Tang Y, Pan Y*, Zhang Z*, Ruan K*. “Conformational Selection in Ligand Recognition by the First Tudor Domain of PHF20L1”. J. Phys. Chem. Lett. 2020, 11:7932-7938.

[6] Xu D#, Li B#, Gao J#, Liu Z, Niu X, Nshogoza G, Zhang J, Wu J, Su XC, He W, Ma R*, Yang D*, Ruan K*. “Ligand Proton Pseudocontact Shifts Determined from Paramagnetic Relaxation Dispersion in the Limit of NMR Intermediate Exchange”. J. Phys. Chem. Lett. 2018, 9:3361-3367.

[8] Fumei Zhong, Yu Zhou, Mingqing Liu, Lei Wang, Fudong Li, Jiahai Zhang, Zhiyong Han, Yunyu Shi*, Jia Gao*, Ke Ruan*. Repurposing Tolfenamic Acid to Anchor the Uncharacterized Pocket of the PUB Domain for Proteolysis of the Atypical E3 ligase HOIP. ACS Chemical Biology. 2024 Nov 8.

[9] Tang H, Wang L, Li S, Wei X, Lv M, Zhong F, Liu Y, Liu J, Fu B, Zhu Q, Wang D, Liu J, Ruan K, Gao J*, Xu W*. Inhibitors against Two PDZ Domains of MDA-9 Suppressed Migration of Breast Cancer Cells. Int J Mol Sci. 2023 Feb 8;24(4):3431.

[10] Wei X, Li S, Li Z, Wang L, Fan W, Ruan K*, Gao J*. Fragment-based discovery of small molecule inhibitors of the HDGFRP2 PWWP domain. FEBS Lett. 2024 Jul 19. PMID: 39031937.


发表专利情况:

罗替戈汀的抗多发性骨髓瘤活性与应用: 专利号ZL 2023 1 1417316.6